Thumbnail Image
Publication

Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis.

Crosbie, Emma J
; 
Zwahlen, M
; 
Kitchener, Henry C
; 
Egger, M
; 
Renehan, Andrew G
Citations
Altmetric:
Abstract
Body mass index (BMI) is a risk factor for endometrial cancer. We quantified the risk and investigated whether the association differed by use of hormone replacement therapy (HRT), menopausal status, and histologic type.
Authors
Crosbie, Emma J
Zwahlen, M
Kitchener, Henry C
Egger, M
Renehan, Andrew G
Affiliation
Gynaecology Oncology Research Group, School of Cancer and Enabling Sciences, University of Manchester, Manchester, UK.
Description
Date
2010-12
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
Main article
Adobe PDF, 446.23 KB
Keywords
Body Mass Index
Hormone Replacement Therapy
Endometrial Cancer
Type
Article
Citation
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. 2010, 19 (12):3119-30 Cancer Epidemiol Biomarkers Prev
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/120132
Embedded videos